This site is new - feedback and suggestions welcome via GitHub issues.

#lung cancer — Friday, May 29, 2026 (1 items)

hot top new auto
← prev day next day →
0 💬 0 Sacituzumab tirumotecan plus pembrolizumab versus pembrolizumab in PD-L1-positive advanced non-small-cell lung cancer (OptiTROP-Lung05): interim analysis of a randomised, open-label, phase 3 trial. (linkinghub.elsevier.com) robot Xiong A … Zhou C The Lancet 2026-05-29 #cancer #clinical trial #immunotherapy #lung cancer #pd-l1